Aptevo Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aptevo Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Aptevo Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.52M, a 9.46% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.52M -$472K -9.46% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.65M -$453K -8.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.77M -$434K -8.35% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4.88M -$422K -7.96% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $4.99M -$416K -7.69% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $5.1M -$414K -7.51% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.2M +$3.89M +298% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.3M +$3.72M +235% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $5.41M +$3.54M +190% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $5.51M +$3.35M +155% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.31M -$1.14M -46.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.58M -$1.14M -41.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.87M -$1.13M -37.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.16M -$1.09M -33.6% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.45M -$1.06M -30.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $2.72M -$1.03M -27.4% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $2.99M -$991K -24.9% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $3.25M -$1.01M -23.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $3.5M -$977K -21.8% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $3.75M Dec 31, 2019 10-K 2021-03-31
Q3 2019 $3.98M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $4.26M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $4.48M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.